|
|
|
Publications
|
Acute Adverse Reactions to Gadolinium based Contrast Agents in Cardiovascular MR. Multi-Centre Experience With 17767 Patients From the EuroCMR Registry.
Bruder O et al. JAC 2011 [in press]
Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy.
Bruder O, Wagner A, Jensen CJ, Schneider S, Ong P, Kispert EM, Nassenstein K, Schlosser T, Sabin GV, Sechtem U, Mahrholdt H.
J Am Coll Cardiol. 2010 Sep 7;56(11):875-87.
|
Lessons Learned from the European Cardiovascular Magnetic Resonance (EuroCMR) Registry Pilot Phase
Bruder O, Wagner A, Mahrholdt H
Curr Cardiovasc Imaging Rep 2010 Jun 3(3):171-174
|
Current variables, definitions and endpoints
of the European Cardiovascular Magnetic Resonance Registry.
Wagner A, Bruder O, Schneider S, Nothnagel D, Buser P, Pons-Lado G, Dill T, Hombach V, Lombardi M, van Rossum AC, Schwitter J, Senges J, Sabin GV, Sechtem U, Mahrholdt H, Nagel E.
J Cardiovasc Magn Reson. 2009 Nov 5;11(1):43.
|
EuroCMR (European Cardiovascular Magnetic Resonance) registry: results of the German pilot phase.
Bruder O, Schneider S, Nothnagel D, Dill T, Hombach V, Schulz-Menger J, Nagel E, Lombardi M, van Rossum AC, Wagner A, Schwitter J, Senges J, Sabin GV, Sechtem U, Mahrholdt H.
J Am Coll Cardiol. 2009 Oct 6;54(15):1457-66
|
|
|
